A Study to Determine the Pharmacokinetic and Pharmacodynamic Profiles of PROCRIT (Epoetin Alfa) in Anemic Patients With Chronic Kidney Disease - Related Studies

A Study to Determine the Pharmacokinetic and Pharmacodynamic Profiles of PROCRIT (Epoetin Alfa) in Anemic Patients With Chronic Kidney Disease

This study has been completed.

Study NCT00641589. Last updated on March 17, 2008. Information provided by Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Anemia
		Chronic Kidney Disease

2	Additional conditions recognized in this trial
		Kidney Diseases
		Kidney Failure, Chronic

3	More general conditions related to this trial
		Hematologic Diseases
		Kidney Failure
		Renal Insufficiency
		Renal Insufficiency, Chronic
		Urologic Diseases

4	Interventions listed in this trial
		epoetin alfa

5	More general drug interventions related to this trial
		Hematinics
		Hematologic Agents
		Pharmacologic Actions
		Therapeutic Uses

6	Sponsors listed in this trial
		Johnson &Johnson Pharmaceutical Research &Development, L.L.C.
		Centocor Ortho Biotech Services, L.L.C.